chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"Vaccine impaired my menstrual cycle"; This spontaneous case was reported by an other health care professional and describes the occurrence of MENSTRUAL DISORDER ("Vaccine impaired my menstrual cycle") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUAL DISORDER ("Vaccine impaired my menstrual cycle"). At the time of the report, MENSTRUAL DISORDER ("Vaccine impaired my menstrual cycle") outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products and treatment information were reported.
muscle soreness at the injection site; This is a spontaneous report from a contactable pharmacist (patient). A 52-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247) at the age of 52-years-old, via an unspecified route of administration on left arm on 04Feb2021 at 09:30 AM at single dose for COVID-19 immunization. The patient's medical history was not reported. She was not pregnant at the time of vaccination. Concomitant medications included levothyroxine and multivitamin. The facility where the most recent COVID-19 vaccine was administered was at the workplace clinic (also reported as other). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient experienced muscle soreness at the injection site on 05Feb2021. The patient did not receive any treatment in response to the event. The outcome of the event was recovering. The event was assessed as non-serious.
Information has been received from a licensed practical nurse concerning multiple unspecified patients of unknown ages and genders. The patients' pertinent medical history, drug reactions/allergies and concurrent conditions were not informed. On unknown dates, the patients were administered improperly stored doses of PROQUAD lots # M012986 and M021428 with expiration dates 12-SEP-2017 and 29-OCT-2017 respectively, (dosages and therapy routes were not provided), for prophylaxis. Concomitant therapies were not informed. The doses of measles, PROQUAD were exposed to a temperature of 21.3 degree centigrade and were out of range for 1 hour. A data logger was used to track the temperature and there were no prior excursions. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports from the same source. Follow up information has been received from the nurse on 17-NOV-2016. On unknown dates, an unspecified number of patients received improperly stored PROQUAD (lots # M012986 and M021428 with expiration dates 12-SEP-2017 and 29-OCT-2017 respectively, dose and route were not provided) for prophylaxis. No adverse effect was reported. More temperature excursion details were provided: the vaccines had been exposed under the temperature -16.0 degree centigrade for 5 hours and 46 minutes on 09-NOV-2016, -6.8 degree centigrade for 16 hours 34 minutes on 10-NOV-2016, -8.4 degree centigrade for 15 hours 35 minutes on 12-NOV-2016, -11.4 degree centigrade for 17 hours 38 minutes on 13-NOV-2016, -11.1 degree centigrade for 10 hours and 51 minutes on 14-NOV-2016, -16.2 degree centigrade for 22 minutes on 15-NOV-2016. Previous excursion included: on 12-SEP-2016, -8.7 degree centigrade for 9 hours 18 minutes; on 16-SEP-2016, -7.7 degree centigrade for 11 hours 39 minutes; on 23-SEP-2016, -9.5 degree centigrade for 9 hours 35 minutes; on 16-OCT-2016, -8.5 degree centigrade for 14 hours 48 minutes; on 25-OCT-2016, -6.8 degree centigrade for 10 hours 8 minutes; on 04-NOV-2016, -7.6 degree centigrade for 9 hours 45 minutes. Data logger issue was involved. Additional information has been requested. Reporter, adverse event information and narrative were updated. Sender's Comments:  US-009507513-1611USA004908: US-009507513-1611USA004924: US-009507513-1611USA004925: US-009507513-1611USA004926: US-009507513-1611USA004927: US-009507513-1611USA004928: US-009507513-1611USA004929: US-009507513-1611USA004931: US-009507513-1611USA013266: MERCK 1611USA004930: Mfr number.
Patient fainted after getting vaccine and was coming to pick up window to collect the paper work. After few minutes he was fine,  talking and also get up and sit in our waiting area, drink water (almost full bottle). We let him wait for caregiver to pick him up and make sure he is not driving by accompany him upto the car.
joint pain; muscle pain; chills; flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and CHILLS (chills) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). On 04-Feb-2021, the patient experienced ARTHRALGIA (joint pain), MYALGIA (muscle pain) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), ARTHRALGIA (joint pain), MYALGIA (muscle pain) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Patient email and address was added
Bruising on the back of both legs and both arms.  Some discomfort in right arm.
I gave the PNEUMOVAX vaccine first and he said he felt nothing but when I gave the FLUZONE HD he said he felt it immediately and he came back a couple days later because it was so red and painful. The redness and pain lasted about a week and he described the pain as being very bad but he didn't want to go to a doctor. It got better without.
Chills; Sweats; Body aches; Left arm hurts; Headache; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old unspecified gender patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 12Mar2021 at 16:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021 at 14:00 the patient experienced chills, sweats, head and body aches and left arm hurts only the day after vaccination, left arm hurt was still there after 3 days also when reported by patient. Therapeutic measures were taken as a result of chills, sweats, head and body aches and left arm hurts and included treatment with paracetamol (TYLENOL)  reported by the patient that it helped. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, sweats, head and body aches was recovered on an unknown date in Mar2021 while left arm hurts was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Moderna COVID-19 Vaccine EUA; 99.5 fever, chills, muscle aches, night sweats
Baby was co-sleeping between parents and was found unresponsive and already rigid at around 6:30 am. Last known awake time was 3-3:30 am. Resuscitation attempted by unsuccessful. Full autopsy report is not completed at this time but the latest I heard from the mother of the baby is that there was no obvious cause on the exam of the baby and internal organs. There are tissue sample tests pending.
Information has been received from a certified medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history was not reported. On 06-APR-2015 the patient was vaccinated with a dose of improperly stored (Oka/Merck) VARIVAX (strength, dose, route, lot# and expiration date unknown). No adverse effects were reported. No product quality complaint (PQC) was reported for (Oka/Merck) VARIVAX. Follow up information has been received from the certified medical assistant on 06-AUG-2015 referring to the 12 (also reported as 16) months old female child. Pre-existing allergies, birth defects and medical conditions were not known. On 06-APR-2015 11:36 AM the patient vaccinated with the first dose of improperly stored (Oka/Merck) VARIVAX, (lot# K011804, expiration date was unknown) subcutaneously in the Left Vastus Lateralis (LVL), which was then recalled due to possible temperature compromise. The patient had no illness at time of vaccination. The patient was received with (Oka/Merck) VARIVAX on an unknown date of July 2015. Additional information is not expected as follow up information has been received. Patient information, product information and narrative were updated.
29 Mar 07 developed rash all over body that lasted approx. 3 days/ took benedryl or claritin for releif.  3Apr 07 lymph nodes became tender and enlarged.  5 Apr 07 lymph nodes hot, red, sore, and itchy accompanied by nausea, vomiting, diarrhea, and fever that desipated on 8 Apr 07.  some lymph nodes are still enlarged and have had a hard time sleeping through the night since I received the vaccinations.
Initial report was received 12 January 2011 from a health care professional. A 53-year-old male patient had received a left deltoid injection of ADACEL, lot number C3486AA and a right arm injection of PNEUMOVAX (manufacturer and lot number not reported) on 25 August 2010 and on the day of vaccination, he developed a hard area at the left arm injection site. He had no swelling, redness or soreness at that time. "Now", the patient reported that the left arm injection site was sore and hot to touch. He was evaluated by his health care provider (date not reported) who reported that the left arm injection site had a 2 x 2.5 cm blister that was peeling; there was no reported weakness, no fever and no discoloration. He received corrective treatment for an abscess which consisted of Cephalexin 500 mg four times daily for 10 days, then two times daily for 10 days. He was also to be scheduled to follow-up with a dermatologist in one month for possible drainage of the abscess. The patient had a past history of diabetes, elevated blood pressure, elevated cholesterol, diverticulosis and a vitamin D deficiency and he had been taking Amlodipine, PRINZIDE, Metformin, ACTOS, Simvastatin, ASA 81mg and Vitamin D3 concomitantly. He had no reported illness at the time of vaccination. The event outcome was entered as unknown; however, per the narrative description, the event was not recovered. Documents held by sender: None.
Extremely allergic itching reaction; Whole skin is red; I have been ripping my skin apart; Extremely allergic itching reaction; This is a spontaneous report from a contactable consumer or other non-healthcare professional (Patient). A patient of unspecified age and gender received BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection and (Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient after got the shot, experienced extremely allergic itching reaction since 08Jun2021, have been ripping the skin apart and the whole of skin was red. Patient went to two doctors and they said that it was probably a reaction and then patient need to call Pfizer that took a medical report figure out to do about itching. Outcome of the event was unknown.  Limited information available over the call.  Information about batch/lot number has been requested.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt received dose #1 Moderna COVID vaccine 1/19/21 @ LPH Vaccine clinic. Overnight some nausea, malaise. 1/20/21 experienced a syncopal episode at home and BIBA to PVH ED. Vomiting, incontinence in route. Workup negative, given IVF and zofran, discharged. Per ED provider "Likely vasovagal syncope. Possibly related to reaction to vaccine. No worrisome findings in the evaluation today."
tired/wants to lay down; cold; temperature of 99.6; shivers; diarrhea; throwing up; feeling sick; ached; This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd June 2020, the patient received the 1st dose of Shingrix. On 23rd June 2020, less than a day after receiving Shingrix, the patient experienced feeling unwell and pain. On 24th June 2020, the patient experienced fever, shivers, diarrhea, vomiting and cold. On 25th June 2020, the patient experienced tiredness. On an unknown date, the outcome of the feeling unwell, fever, shivers, diarrhea, vomiting and cold were recovered/resolved and the outcome of the pain and tiredness were not recovered/not resolved.   It was unknown if the reporter considered the feeling unwell, pain, fever, shivers, diarrhea, vomiting, tiredness and cold to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and started feeling sick.  The patient ached all over, had a temperature of 99.6, was cold with shivers.  The patient developed diarrhea and throwing up.  The patient temperature, feeling cold, shivers, diarrhea and throwing up had all resolved.  The patient was still achy and was tired on the day of reporting, wanted to lay down. The reporter consented to follow up.
When I received the injection, I experienced a sharp intense burning pain which shot up my shoulder, neck and behind my ear. This has never happened before. My shoulder/arm were sore for approximately one week which seemed typical to how I respond to a vaccine. After a week I began experiencing a sharp pain in my neck and shoulder area which has gradually worsened to where I am now icing it multiple times per day. There is also numbness and tingling down my forearm and into my thumb and index finger.  The pain is unmanageable at times and I am unable to get a full nights rest and have near constant pain when keyboarding.
At time of vaccine patient had tingly arm. Day after, patient could not get warm, had body aches, cough, diarrhea
I started to cough uncontrollably and then felt a lump in my throat.  Breathing became difficult and I was wheezing. I took a Zyrtec and it calmed. The lump in my throat feeling went away and the cough was not as persistent. I then felt weak and got a fever.  From there, my fever got worse and I had severe back pain.  I also started to feel like something was crawling under my collarbone and then felt a sharp pain in localized areas of my back that slowly spread out.  My fever eventually went down to 99 and I went to bed. This morning, my entire body was sore and I felt drained.  I continue to feel drained and weak today. I probably should have gone to the doctors but hate going to emergency rooms. I do not feel like myself yet.
Low grade fever, chills, muscular/body aches, tiredness, sleepiness, very sore arm. Lasted for 48 hours.
Headache, body aches, nausea, malaise, soreness at injection site, chills
Patient is working for Fedex.  She was at work yesterday. Patient developed slurred speech and right facial droop. She has history of migraine. On average, she has once attack per month. Yesterday, she has severe frontal headache. Blurry vision.  Her had was similar to her past migraine.  Her coworker at work thought that patient was odd in talking to them.    Patient the went home. Her symptoms all subsided. This am, she was driving to work.  She did not have blurry vision. However she realized that her car veering to other lane. She had to bring it back to the right lane. She arrived to work then called Advice RN. They asked her to come to ED. CT OF HEAD: Acute 1.5 cm infarct involving the posterior limb of right internal capsule. No hemorrhage or significant mass effect. PATIENT PENIDNG MRI BRAIN.
fever; Normal headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and HEADACHE (Normal headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PYREXIA (fever) and HEADACHE (Normal headache). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Headache, at an unspecified dose and frequency. At the time of the report, PYREXIA (fever) and HEADACHE (Normal headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.
LEFT BELLS PALSY RIGHT FACIAL MUSCLE WEAKNESS 7/23/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Headache, Myalgia, Arthralgia, NauseaVomiting,  Fatigue Narrative:
Headache for 12 hours, starting at 8pm on night of injection; Shivering for 10 hours, starting at 10pm on night of injection; Severe fatigue for 20 hours, starting at 8pm on night of injection.  Unable to perform normal activities during that time, including difficulty sleeping and working the next day.
This case was reported by a physician via sales representative and described the occurrence of fever in a subject of unspecified age and gender who was vaccinated with PEDIARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included PEDVAXHIB (non-gsk); non-GSK manufacturer; unknown given on an unspecified date; PREVNAR (non-gsk); non-GSK manufacturer; unknown; unknown given on an unspecified date. On an unspecified date the subject received 1st dose of PEDIARIX (unknown). At an unspecified time after vaccination with PEDIARIX, the subject experienced fever of 105 degrees Fahrenheit (F). At the time of reporting the outcome of the fever of 105F was unspecified.
About 24 hours post injection, the injection site is raised hard warm to touch and red covering a good portion of my upper arm . Also was accompanied by a severe headache for 12 hours with no relief from Tylenol, Motrin or ice on the injection site .
9/16 sore throat, fever 101 degrees, sore left forearm, stomach ache, sweats and chills, body aches- treated with ibuprofen - called doctors office to see if needed to bring him in didn't advise as long as treatment at home was working  9/17 all above plus cough developed and worsened needed nebulizer treatment - treated with Levalbuterol and Budesonide continued Nebulizer treatments from 9/17-9/20 From 9/20-10/1 congested and stuffy nose
The second week after I got the vaccine I started to have a pressure headache on the side of my head and down my neck. My leg was painful by my knee and it lasted a week. I had the headache and the pain at the back of my neck for one week. The pain medication did not help with the pain. The headache was on both sides but much worse on the right.  I had a bump on the back of my neck on the right that was painful. I had a rash on my arm around the site of the injection about an inch around which is still visible after three weeks. The rash was a little itchy.
Two days after getting the vaccine I started getting red pimples on the face and they hurt, and after 10 days of getting the vaccine redness on the site that I got the vaccine
The day following my booster shot, I got a very tender sometimes painful swollen lump under my right arm. Located where the chest and axilla meet.; The day following my booster shot, I got a very tender sometimes painful swollen lump under my right arm. Located where the chest and axilla meet.; Dose number 3; This is a spontaneous report received from a non-contactable reporter (consumer or other non-HCP). The reporter is the patient.   An adult female patient (not pregnant) received bnt162b2 (BNT162B2), administered in right arm, administration date 05Jan2022 at 16:00 (Lot number: FL3209) as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history was not reported. Patient did not receive any concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: EM9809, Route of Administration: unspecified), for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot Number: ER2613, Route of Administration: unspecified), for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 05Jan2022 at 16:00, outcome "unknown", described as "Dose number 3"; AXILLARY MASS (non-serious), AXILLARY PAIN (non-serious) all with onset 06Jan2022, outcome "recovered" (10Jan2022), and all described as "The day following my booster shot, I got a very tender sometimes painful swollen lump under my right arm. Located where the chest and axilla meet". Therapeutic measures were not taken as a result of axillary mass and axillary pain.  Additional Information: Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. It was reported that the tender swelling remained for 4 days. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  No follow-up attempts are possible. No further information is expected.
The patient's arm was bleeding upon removing the needle (more than a couple drops) and the patient's arm immediately began swelling after the injection.  The patient did not seem to be in any distress, and stated she was having no pain.
Client was shopping at a grocery store, and noticed she started itching on her abdominal area.  Large reddened hives noted to abdominal area.